These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31810944)

  • 1. Development of Normal Tissue Complication Probability Model for Trismus in Head and Neck Cancer Patients Treated With Radiotherapy: The Role of Dosimetric and Clinical Factors.
    Morimoto M; Bijl HP; VAN DER Schaaf A; Xu CJ; Steenbakkers RJHM; Chouvalova O; Yoshioka Y; Teshima T; Langendijk JA
    Anticancer Res; 2019 Dec; 39(12):6787-6798. PubMed ID: 31810944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic training for the prevention of radiotherapy-induced trismus - a randomised study.
    Loorents V; Rosell J; Karlsson C; Lidbäck M; Hultman K; Börjeson S
    Acta Oncol; 2014 Apr; 53(4):530-8. PubMed ID: 24635110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predictive nomogram for trismus after radiotherapy for head and neck cancer.
    Massaccesi M; Dinapoli N; Fuga V; Rupe C; Panfili M; Calandrelli R; Settimi S; Olivieri M; Beghella Bartoli F; Mazzarella C; Longo S; Lajolo C; Boldrini L; Gambacorta MA; Valentini V; Miccichè F
    Radiother Oncol; 2022 Aug; 173():231-239. PubMed ID: 35662658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients.
    Gebre-Medhin M; Haghanegi M; Robért L; Kjellén E; Nilsson P
    Acta Oncol; 2016 Nov; 55(11):1313-1317. PubMed ID: 27595312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Kraaijenga SA; Hamming-Vrieze O; Verheijen S; Lamers E; van der Molen L; Hilgers FJ; van den Brekel MW; Heemsbergen WD
    Head Neck; 2019 May; 41(5):1387-1394. PubMed ID: 30652390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trismus in head and neck cancer patients treated by telecobalt and effect of early rehabilitation measures.
    Nagaraja S; Kadam SA; Selvaraj K; Ahmed I; Javarappa R
    J Cancer Res Ther; 2016; 12(2):685-8. PubMed ID: 27461633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective 5-year study of trismus prevalence and fluctuation in irradiated head and neck cancer patients.
    Aghajanzadeh S; Karlsson T; Engström M; Tuomi L; Finizia C
    Acta Otolaryngol; 2022; 142(7-8):620-626. PubMed ID: 35881768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trismus in head and neck cancer patients in Sweden: incidence and risk factors.
    Johnson J; van As-Brooks CJ; Fagerberg-Mohlin B; Finizia C
    Med Sci Monit; 2010 Jun; 16(6):CR278-82. PubMed ID: 20512090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal patterns of patient-reported trismus and associated mouth-opening distances in radiotherapy for head and neck cancer: A prospective cohort study.
    Thor M; Olsson CE; Oh JH; Hedström J; Pauli N; Johansson M; Deasy JO; Finizia C
    Clin Otolaryngol; 2018 Feb; 43(1):22-30. PubMed ID: 28463432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; Burlage FR; Koken PW; Doornaert P; Bijl HP; Chouvalova O; Leemans CR; de Bock GH; Christianen ME; van der Laan BF; Vissink A; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):86-93. PubMed ID: 21632133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal Tissue Complication Probability (NTCP) Prediction Model for Osteoradionecrosis of the Mandible in Patients With Head and Neck Cancer After Radiation Therapy: Large-Scale Observational Cohort.
    van Dijk LV; Abusaif AA; Rigert J; Naser MA; Hutcheson KA; Lai SY; Fuller CD; Mohamed ASR;
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):549-558. PubMed ID: 33965514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trismus in patients with head and neck cancer and 5-year overall survival.
    Astradsson T; Laurell G; Ahlberg A; Nikolaidis P; Johansson H; Ehrsson YT
    Acta Otolaryngol; 2018 Dec; 138(12):1123-1127. PubMed ID: 30686104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT).
    Owosho AA; Pedreira Ramalho LM; Rosenberg HI; Yom SK; Drill E; Riedel E; Tsai CJ; Lee NY; Huryn JM; Estilo CL
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1408-13. PubMed ID: 27377999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trismus, health-related quality of life, and trismus-related symptoms up to 5 years post-radiotherapy for head and neck cancer treated between 2007 and 2012.
    Aghajanzadeh S; Karlsson T; Tuomi L; Engström M; Finizia C
    Support Care Cancer; 2023 Feb; 31(3):166. PubMed ID: 36781552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced trismus in the ARTSCAN head and neck trial.
    Lindblom U; Gärskog O; Kjellén E; Laurell G; Levring Jäghagen E; Wahlberg P; Zackrisson B; Nilsson P
    Acta Oncol; 2014 May; 53(5):620-7. PubMed ID: 24669774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise intervention for the treatment of trismus in head and neck cancer - a prospective two-year follow-up study.
    Pauli N; Svensson U; Karlsson T; Finizia C
    Acta Oncol; 2016 Jun; 55(6):686-92. PubMed ID: 26878553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible].
    Pointreau Y; Lizée T; Bensadoun RJ; Boisselier P; Racadot S; Thariat J; Graff P
    Cancer Radiother; 2016 Oct; 20(6-7):445-51. PubMed ID: 27614524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer.
    Wopken K; Bijl HP; van der Schaaf A; van der Laan HP; Chouvalova O; Steenbakkers RJ; Doornaert P; Slotman BJ; Oosting SF; Christianen ME; van der Laan BF; Roodenburg JL; Leemans CR; Verdonck-de Leeuw IM; Langendijk JA
    Radiother Oncol; 2014 Oct; 113(1):95-101. PubMed ID: 25443500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced mouth opening in patients with head and neck cancer treated with radiation therapy: an analysis of the Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
    Sollecito TP; Helgeson ES; Lalla RV; Treister NS; Schmidt BL; Patton LL; Lin A; Brennan MT
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):264-273. PubMed ID: 38262773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.